New cancer drug tested in Head-to-Head trial
NCT ID NCT07435311
Summary
This study compared a new drug called RPH-002 to an existing drug, Erbitux®, for people with advanced head and neck cancer that had returned or spread. The main goals were to see if the body processed the two drugs similarly and to check their safety when given with standard chemotherapy. It involved 118 participants and was an early-stage (Phase 1) trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Autonomous Institution of the Chuvash Republic "Republican Clinical Oncological Dispensary" of the Ministry of Health of the Chuvash Republic
Cheboksary, 428020, Russia
-
Budgetary Healthcare Institution of Omsk Region "Clinical Oncological Dispensary"
Omsk, 644013, Russia
-
Federal State Autonomous Higher Education Institution "First Moscow State Medical University named after I.M. Sechenov" of the Ministry of Health of the Russian Federation (Sechenov University)
Moscow, 119435, Russia
-
Federal State Budgetary Institution "National Medical Research Center of Radiology" of the Ministry of Health of the Russian Federation, Branch: A.F. Tsyba Medical Radiological Research Center
Obninsk, 249036, Russia
-
Joint-Stock Company "Medsi Group of Companies"
Moscow, 143442, Russia
-
Limited Liability Company "COMPAS-LA"
Moscow, 119602, Russia
-
Private Medical Institution "Euromedservice"
Pushkin, 196603, Russia
-
Regional Budgetary Healthcare Institution "Ivanovo Regional Oncological Dispensary"
Ivanovo, 153040, Russia
-
Regional State Budgetary Healthcare Institution "Altai Regional Oncological Dispensary"
Barnaul, 656045, Russia
-
Saint Petersburg State Budgetary Healthcare Institution "City Clinical Oncological Dispensary"
Saint Petersburg, 197022, Russia
-
State Autonomous Healthcare Institution "Republican Clinical Oncological Dispensary" of the Ministry of Health of the Republic of Bashkortostan
Ufa, 450054, Russia
-
State Budgetary Healthcare Institution "Leningrad Regional Clinical Hospital"
Kuz'molovskiy, 191104, Russia
-
State Budgetary Healthcare Institution "Regional Oncological Dispensary"
Irkutsk, 664035, Russia
-
State Budgetary Healthcare Institution of Kaluga Region "Kaluga Regional Clinical Oncological Dispensary"
Kaluga, 248007, Russia
-
State Budgetary Healthcare Institution of Moscow "City Clinical Hospital named after S.S. Yudin, Department of Health of Moscow"
Moscow, 129090, Russia
-
State Budgetary Healthcare Institution of Moscow "Moscow City Oncological Hospital No. 62, Department of Health of Moscow"
Istra, 143515, Russia
-
State Budgetary Healthcare Institution of Novosibirsk Region "Novosibirsk Regional Clinical Oncological Dispensary"
Novosibirsk, 630108, Russia
-
State Budgetary Healthcare Institution of Yaroslavl Region "Regional Clinical Oncological Hospital"
Yaroslavl, 150054, Russia
Conditions
Explore the condition pages connected to this study.